- Report
- December 2021
Global
From €4662EUR$4,850USD£3,997GBP
- Report
- January 2020
Japan, United States, ... Japan, United States, Europe, Global
From €3700EUR$3,850USD£3,173GBP
The Lymphogranuloma Diagnostic market is a subset of the Diagnostics industry, focusing on the diagnosis of lymphogranuloma venereum (LGV). This sexually transmitted infection is caused by a type of Chlamydia bacteria and is most common in tropical and subtropical regions. Diagnosis of LGV is typically done through a combination of physical examination, laboratory tests, and imaging. Treatment typically involves antibiotics, and in some cases, surgery.
The Lymphogranuloma Diagnostic market is highly competitive, with a number of companies offering products and services. These include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, and Roche Diagnostics. Show Less Read more